Skip to content

Category

gene editing

1,411 papers

#gene editing Open access Sep 2026

CRISPR/Cas9-Mediated Editing of Terpene Synthase Gene Reduces Volatile Emission and Attraction of Hypothenemus hampei to Coffea arabica Fruits

The coffee berry borer (CBB), Hypothenemus hampei (Ferrari) (Coleoptera: Curculionidae: Scolytinae), is one of the most destructive pests of coffee, causing significant losses in yield, bean quality, and overall crop profitability. Current integrated pest management strategies reduce damage but cannot prevent insects f...

Paula A. Figueroa-Varela, C. Góngora, Claudia P. Martínez et al. · 0 citations
#gene editing Open access Sep 2026

Engineering circular RNA expression systems to minimize contaminating linear RNA byproducts

Circular RNAs (circRNAs) are generated by backsplicing of eukaryotic protein-coding transcripts and can regulate microRNAs and RNA binding proteins, or serve as translation templates. Their covalently closed structure confers resistance to exonuclease-mediated degradation, extending their half-life and supporting their...

Christopher J. Fields, Rina Fujiwara, Bradley W. Wright et al. · 0 citations
#gene editing Open access Sep 2026

Evaluation of Alcalase pretreatment for Chlamydomonas reinhardtii CRISPR knock-in

We wanted to use CRISPR-Cas9-mediated homology-directed repair (HDR) in C. reinhardtii to insert genomic landing pads as part of a larger project. In cell-walled algae, delivering Cas9 ribonucleoproteins (RNPs) and donor DNA requires first digesting that wall. The standard approach uses autolysin, a gamete-derived prot...

Daniel Caddell, Raymond Futia, James Aaron Kraemer · 0 citations
#gene editing Review Open access Sep 2026

Beyond Precision: A Multidimensional Framework for Selecting Genetic Medicine Platforms

A multidimensional framework is proposed in which gene therapy platforms are evaluated according to three intrinsic properties—genetic precision, temporal control, and dosage tunability—while delivery, clinical maturity, and disease context act as major translational constraints.

Jared Wieland, Peyton Jackson, William Penrod et al. · 0 citations
#gene editing Open access Sep 2026

Lipoprotein(a) as an independent cardiovascular risk factor

Emerging evidence links Lp(a) to atrial fi brillation, broadening its clinical relevance and integrating Lp(a) testing into risk assessment and preparing for targeted therapies are critical steps in modern cardiovas-cular prevention.

L. Kopaleishvili, T. Chkhaidze, S. Ungiadze et al. · 0 citations
#gene editing Open access Sep 2026

An inducer-independent, single-plasmid CRISPR-Cas9 system for genome editing in Bacillus species

A one-step CRISPR-based transformation protocol developed in this study enables fast genome editing workflows with minimal hands-on time and demonstrates the versatility of the modified system for this industrially important genus.

Maximilian Hilkmann, Norma Welsch, M. F. Felle et al. · 0 citations
#gene editing Open access Sep 2026

The Cucurbita ficifolia Mitochondrial Genome: Repeat-Rich Architecture, Plastid Homology, and Synteny Turnover Across Cucurbitaceae

Background: Cucurbita ficifolia (figleaf gourd) is an agriculturally useful cucurbit germplasm and rootstock, but its mitochondrial genome has not been examined in a comparative family-level framework. We aimed to characterize its mitochondrial reference sequence and evaluate coding composition, repetitive DNA, plastid...

Jun Yang, Xin-Hui Li, Hui-Lin Cheng et al. · 0 citations
#gene editing Dataset Open access Sep 2026

EFFECTIVENESS OF TREATING GENETIC DISEASES BY GENE THERAPY

This article analyzes the effectiveness of gene therapy in treating genetic diseases, its main molecular mechanisms, and modern technologies. Key therapeutic approaches such as gene addition, gene function restoration, gene expression silencing, and targeted genome editing are covered. The potential of modern gene deli...

Olloqulova Khosiyat Kuvondik qizi, Sharipova Farida Salimjanovna, Worldly Knowledge Publishing Centre · 0 citations
#gene editing Review Open access Sep 2026

Aptamer-mediated CRISPR-Cas9 delivery for precision oncology: integrating molecular targeting, intracellular trafficking, and nanocarrier engineering

Cancer therapy remains constrained by insufficient molecular specificity, intratumoral heterogeneity, and the emergence of therapeutic resistance that limit durable clinical responses. CRISPR Cas9 genome editing offers an unprecedented opportunity to directly reprogram oncogenic drivers, tumor suppressor pathways, and...

Abolfazl Saffari Natanzi, Elina Ahmadi, Sajjad Shahraki et al. · 0 citations

From tech blogs

See all →
Google DeepMind Blog Sep 30, 2026

Introducing SynthID Bio

Proof of concept for watermarking AI-generated proteins while preserving biological function.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.